Percutaneous Aortic Valve Replacement in Patients with Challenging Aortoiliofemoral Access

被引:8
作者
Jilaihawi, Hasan [1 ]
Spyt, Tomasz [1 ]
Chin, Derek [1 ]
Logtens, Elaine [1 ]
Laborde, Jean-Claude [1 ]
Kovac, Jan [1 ]
机构
[1] Glenfield Gen Hosp, Dept Cardiol, Leicester LE3 9QP, Leics, England
关键词
valvular heart disease; peripheral vascular disease; complications adult cath/intervention; corevalve; percutaneous aortic valve replacement (PAVR); transcatheter aortic valve implantation;
D O I
10.1002/ccd.21630
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Percutaneous aortic valve replacement (PAVR) offers considerable promise in treating high risk patients with aortic valve disease. Two devices are currently clinically available for transfemoral delivery: the Edwards-Sapien balloon-expandable bioprosthesis and the Corevalve self-expanding bioprosthesis, both of which require careful sizing of the peripheral vasculature. Through a case based discussion, we illustrate that these limits of PAVR technology can be stretched in cases of extraordinary clinical need. We demonstrate that, following a learning curve of "optimal cases," successful PAVR is also possible in diffusely diseased peripheries of borderline small size or with focal aortoiliofemoral disease amenable to a separate intervention beforehand. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:885 / 890
页数:6
相关论文
共 17 条
[1]   Fatal ischemic stroke related to nonpermissive peripheral artery access for percutaneous aortic valve replacement [J].
Berry, Colin ;
Cartier, Raymond ;
Bonan, Raoul .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 69 (01) :56-63
[2]   Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis [J].
Cribier, A ;
Eltchaninoff, H ;
Tron, C ;
Bauer, F ;
Agatiello, C ;
Sebagh, L ;
Bash, A ;
Nusimovici, D ;
Litzler, PY ;
Bessou, JP ;
Leon, MB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (04) :698-703
[3]   Treatment of calcific aortic stenosis with the percutaneous heart valve - Mid-term follow-up from the initial feasibility studies: The French experience [J].
Cribier, A ;
Eltchaninoff, H ;
Tron, C ;
Bauer, F ;
Agatiello, C ;
Nercolini, D ;
Tapiero, S ;
Litzler, PY ;
Bessou, JP ;
Babaliaros, V .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (06) :1214-1223
[4]   TRANSLUMINAL TREATMENT OF ARTERIOSCLEROTIC OBSTRUCTION - DESCRIPTION OF NEW TECHNIC + PRELIMINARY REPORT OF ITS APPLICATION [J].
DOTTER, CT ;
JUDKINS, MP .
CIRCULATION, 1964, 30 (05) :654-&
[5]   Percutaneous aortic valve replacement for severe aortic stenosis in high-rick patients using the second- and current third-generation self-expanding CoreValve prosthesis - Device success and 30-day clinical outcome [J].
Grube, Eberhard ;
Schuler, Gerhard ;
Buellesfeld, Lutz ;
Gerckens, Ulrich ;
Linke, Axel ;
Wenaweser, Peter ;
Sauren, Barthel ;
Mohr, Friedrich-Wilhelm ;
Walther, Thomas ;
Zickmann, Bernfried ;
Iversen, Stein ;
Felderhoff, Thomas ;
Cartier, Raymond ;
Bonan, Raoul .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (01) :69-76
[6]   Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease - The Siegburg First-in-Man Study [J].
Grube, Eberhard ;
Laborde, Jean C. ;
Gerckens, Ulrich ;
Felderhoff, Thomas ;
Sauren, Barthel ;
Buellesfeld, Lutz ;
Mueller, Ralf ;
Menichelli, Maurizio ;
Schmidt, Thomas ;
Zickmann, Bernfried ;
Iversen, Stein ;
Stone, Gregg W. .
CIRCULATION, 2006, 114 (15) :1616-1624
[7]  
Howell M, 2001, J ENDOVASC THER, V8, P68, DOI 10.1583/1545-1550(2001)008<0068:PAACOF>2.0.CO
[8]  
2
[9]   Decision-making in elderly patients with severe aortic stenosis:: why are so many denied surgery? [J].
Iung, B ;
Cachier, A ;
Baron, G ;
Messika-Zeitoun, D ;
Delahaye, F ;
Tornos, P ;
Gohlke-Bärwolf, C ;
Boersma, E ;
Ravaud, P ;
Vahanian, A .
EUROPEAN HEART JOURNAL, 2005, 26 (24) :2714-2720
[10]   A prospective survey of patients with valvular heart disease in Europe:: The Euro Heart Survey on Valvular Heart Disease [J].
Iung, B ;
Baron, G ;
Butchart, EG ;
Delahaye, F ;
Gohlke-Bärwolf, C ;
Levang, OW ;
Tornos, P ;
Vanoverschelde, JL ;
Vermeer, F ;
Boersma, E ;
Ravaud, P ;
Vahanian, A .
EUROPEAN HEART JOURNAL, 2003, 24 (13) :1231-1243